www.diagnosticpathology.org

Table 4
Clinico-pathologic and genetic characteristics of EBV-GC
	Birth year	Diagnostic year	Age	Gender	Lacation	Invasion	Histology Lauren/WHO	EBNA-3 type A/B	BamHI-F type F/"f"	BamHI-I type I/"i"	XhoI +/-

1	1949	1981	32	Male	Lower	Muscle	Diffuse/por1	A	F	"i"	+
2	1929	1982	53	Male	Middle	Muscle	Diffuse/por1	A	F	"i"	-
3	1928	1983	55	Male	Middle	Serosa	Intestinal/tub2	A	F	"i"	+
4	1928	1983	55	Male	Middle	Serosa	Diffuse/por2	A	F	I	+
5	1940	1983	43	Female	Lower	Muscle	Diffuse/por1	A	F	"i"	-
6	1930	1986	56	Male	Middle	Serosa	Diffuse/por2	A	ND¹	"i"	+
7	1928	1988	60	Male	Upper	Serosa	Diffuse/por1	A	F	"i"	+
8	1928	2001	73	Male	Middle	Serosa	Difuse/por2	A	"f'	"i"	-
9	1953	2002	49	Male	Lower	Seroasa	Diffuse/por2	A	"f"	"i"	+

¹Not determined; tub2: moderately differentiated adenocarcinoma por1: solid poorly differentiated adenocarcinoma; por2: non-solid poorly differentiated adenocarcinoma
Abdirad et al. Diagnostic Pathology 2007 2:25 doi:10.1186/1746-1596-2-25

Table 4